AIM:多组分质量改进策略有望改善全球糖尿病护理目标

2016-07-12 崔倩 译 MedSci原创

糖尿病护理目标的实现是全球的理想。以糖尿病为重点的质量改进(QI)是有效的,但在南亚地区还未经测试。该研究的目的是比较多组分QI策略 vs 常规护理对于糖尿病控制不佳患者的心血管代谢的效果。研究人员进行了一项平行,开放性,随机,对照试验。该研究在印度和巴基斯坦的糖尿病诊所进行。该研究共有1146例2型糖尿病和心血管代谢不佳(糖化血红蛋白[HbA1c]水平≥8%加收缩压[BP]≥140 mm Hg和

糖尿病护理目标的实现是全球的理想。以糖尿病为重点的质量改进(QI)是有效的,但在南亚地区还未经测试。

该研究的目的是比较多组分QI策略 vs 常规护理对于糖尿病控制不佳患者的心血管代谢的效果。

研究人员进行了一项平行、开放性、随机对照试验。该研究在印度和巴基斯坦的糖尿病诊所进行。

该研究共有1146例2型糖尿病和心血管代谢不佳(糖化血红蛋白[HbA1c]水平≥8%加收缩压[BP]≥140 mm Hg和/或低密度脂蛋白胆固醇[LDLC]水平≥130 mg/dL)的患者(干预组575例,常规治疗组571例)。

多组分QI策略包括非医生护理协调员和决策支持电子健康记录。

主要终点是实现HbA1c水平低于7%加BP小于130/80mm Hg和/或LDLC水平低于100mg/dL的患者比例;次要终点为平均风险因素的减少,生活健康质量(HRQL),以及治疗满意度。

两组的基线特征是相似的。平均糖尿病病程为7.0年; 分别有6.8%和39.4%的参与者有预先存在的心血管和微血管病变;平均HbA1c水平为9.9%;平均BP为143.3/81.7mm Hg;平均LDLC水平为122.4mg/dL。在平均28个月时,干预组达到主要终点的参与者比例更大(18.2% vs 8.1%;相对风险,2.24[95%CI,1.7至12.92])。与常规治疗相比,干预组的参与者HbA1c水平(-0.50%[CI,-0.69%至-0.32%]),收缩压(-4.04mm Hg[CI,-5.85至-2.22mm Hg]),舒张压(-2.03mm Hg[CI,-3.00到-1.05mm Hg]),以及LDLC水平(-7.86mg/dL[CI,-10.90至-4.81mg/dL])减少的都比较多,并报告有更高HRQL和治疗满意度。

该研究的限制性为研究结果仅限于城市糖尿病专科门诊。

即使在资源受到挑战的诊所,多组分QI也改善了糖尿病护理目标的实现。

原始出处:

Mohammed K. Ali,Kavita Singh,Dimple Kondal,et al.Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals,Ann Intern Med,2016.7.12

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2016866, encodeId=16a52016866ec, content=<a href='/topic/show?id=4579e6722bb' target=_blank style='color:#2F92EE;'>#糖尿病护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76722, encryptionId=4579e6722bb, topicName=糖尿病护理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Fri Feb 24 16:48:00 CST 2017, time=2017-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132021, encodeId=edaa13202192, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:15:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=125681, encodeId=ec0e125681e1, content=对于不同的糖尿病患者,控制目标不能一概而论, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Tue Sep 13 20:10:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936042, encodeId=93e9193604257, content=<a href='/topic/show?id=85d792398e9' target=_blank style='color:#2F92EE;'>#质量改进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92398, encryptionId=85d792398e9, topicName=质量改进)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Mon Apr 03 16:48:00 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2016866, encodeId=16a52016866ec, content=<a href='/topic/show?id=4579e6722bb' target=_blank style='color:#2F92EE;'>#糖尿病护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76722, encryptionId=4579e6722bb, topicName=糖尿病护理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Fri Feb 24 16:48:00 CST 2017, time=2017-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132021, encodeId=edaa13202192, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:15:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=125681, encodeId=ec0e125681e1, content=对于不同的糖尿病患者,控制目标不能一概而论, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Tue Sep 13 20:10:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936042, encodeId=93e9193604257, content=<a href='/topic/show?id=85d792398e9' target=_blank style='color:#2F92EE;'>#质量改进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92398, encryptionId=85d792398e9, topicName=质量改进)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Mon Apr 03 16:48:00 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
    2016-09-21 1e10c84am36(暂无匿称)

    文章很好,非常有益

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2016866, encodeId=16a52016866ec, content=<a href='/topic/show?id=4579e6722bb' target=_blank style='color:#2F92EE;'>#糖尿病护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76722, encryptionId=4579e6722bb, topicName=糖尿病护理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Fri Feb 24 16:48:00 CST 2017, time=2017-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132021, encodeId=edaa13202192, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:15:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=125681, encodeId=ec0e125681e1, content=对于不同的糖尿病患者,控制目标不能一概而论, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Tue Sep 13 20:10:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936042, encodeId=93e9193604257, content=<a href='/topic/show?id=85d792398e9' target=_blank style='color:#2F92EE;'>#质量改进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92398, encryptionId=85d792398e9, topicName=质量改进)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Mon Apr 03 16:48:00 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
    2016-09-13 舒心和人

    对于不同的糖尿病患者,控制目标不能一概而论

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2016866, encodeId=16a52016866ec, content=<a href='/topic/show?id=4579e6722bb' target=_blank style='color:#2F92EE;'>#糖尿病护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76722, encryptionId=4579e6722bb, topicName=糖尿病护理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Fri Feb 24 16:48:00 CST 2017, time=2017-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=132021, encodeId=edaa13202192, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:15:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=125681, encodeId=ec0e125681e1, content=对于不同的糖尿病患者,控制目标不能一概而论, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Tue Sep 13 20:10:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936042, encodeId=93e9193604257, content=<a href='/topic/show?id=85d792398e9' target=_blank style='color:#2F92EE;'>#质量改进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92398, encryptionId=85d792398e9, topicName=质量改进)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Mon Apr 03 16:48:00 CST 2017, time=2017-04-03, status=1, ipAttribution=)]